Background: In recent decades, changes in breast cancer (BC) mortality trends have been observed across Europe.
population age distribution for the period 1977-2001, as well as future population for the period 2002-2016. In Spain, throughout the period 1977-1998, the code for BC was 174 according to the ninth revision of the International Classification of Diseases (ICD-9) [11] , and since 1998, the code was C50 according to the tenth revision of the ICD (ICD-10) [12] . BC mortality rates were age standardised using the world standard population [13] .
Time trends of BC mortality have been evaluated through an age-periodcohort (APC) analysis. Data were arranged in five 5-year periods (1977-1981, 1982-1986, 1987-1991, 1992-1996 and 1997-2001 ) and twelve 5-year age groups (20) (21) (22) (23) (24) to 75-79 years). These age groups and calendar periods involved 16 overlapping 10-year cohorts due to the relation cohort = period ÿ age [14, 15] . The cohort groups were defined by their midyears (starting with 1900 and finishing with the cohort 1975).
The assessment of the age (A), cohort (C) and period (P) effects was carried out by means of generalised linear models assuming that the number of deaths follow a Poisson distribution [14, 15] . A model with the three effects was initially fitted, and then each one of these effects was subsequently extracted in order to find the best-fitting model. To assess model adjustment, we first evaluated the increase (denoted with symbol D) in the deviance (DEV) and second the Akaike Information Criterion (AIC). The model with the lower AIC value was considered the best in terms of model adjustment [14, 15] . In the APC analysis, the relation cohort = period ÿ age is associated with an identification problem in the parameter estimates [14] [15] [16] . We reported these parameter estimates of the full APC model following the same procedure described by Bray et al. [17] in the analysis of the incidence trends of adenocarcinoma of the cervix in Europe. In the first step of this procedure, we fitted an age-cohort (AC) model, using 1952 as the reference cohort. In the second step, we fitted a period effect to the residuals of the AC model by means of a Poisson model for the number of deaths with the log of the fitted values from the AC model as offset. By this procedure, the standard deviations of the estimated values of the effects can be obtained assuming that the secular trend is related with the cohort effect. In this approach, it has been denoted that the resulting effects are close to those obtained with the approach of Holford [16, [18] [19] [20] . We have done the graphical representation of the exponential of each one of these parameters and their 95% confidence intervals (CIs). The statistical software used for this part of the analysis was R [21] . A Bayesian APC model, similar to that described previously by Bashir and Estève [22] , has been applied to predict BC mortality in Spain for the periods 2002-2006, 2007-2011 and 2012-2016 . Constraints on first-order differences were set for the period and cohort effects [23] [24] [25] , whereas a constraint on the second-order differences was set for the age parameters [22] . For this last constraint, it was assumed that one second-order difference is estimated as the mean value on the previous and subsequent second-order differences. This means that for any given age point (3 £ i £ N A ÿ 2; N A : number of age parameters) the conditional expectation of the age effect is obtained through cubic interpolation from the two points on the other side [22] .
To estimate BC projections in Spain, several models were tried on the basis of data from the 1977-2001 period, evaluating its performance and short-term predictions. A tool for the model choice in the Bayesian framework that recently has gained popularity is the Deviance Information Criterion (DIC) [26] , which was proposed as a generalisation of the AIC. The model with lower values of DIC is considered the best-fitting model and with best out-of-sample predictive power [26] . In the initial Bayesian APC model, we could not obtain convergence for the model parameters, although some of the expected number of cases did. This was probably due to the complex autoregressive structure assumed for all parameters. We proceeded to select a model without constraints on the period and cohort terms, which showed the lowest DIC value and fastest convergence compared with all the other models tested. The software used for this analysis was WinBUGS 1.4 [27] which allowed us to carry out Bayesian inference using Gibbs sampling. WinBUGS code for this model is described in the Appendix.
In order to obtain the expected number of BC cases, three chains with 60 000 iterations have been run, discarding the first 10 000 burning samples. Samples from every 10th iteration have been stored (10 was the value for the thin parameter [27] [28] [29] [30] [31] [32] in the run of the Markov chain Monte Carlo) in order to reduce autocorrelation in the sample and Monte Carlo errors [31, 32] . The plots of the sample trace and the Gelman and Rubin convergence diagnostics [31, 32] were used to check for convergence of the chains. R2WinBUGS library was used as an interface to run WinBUGS within R [33] . After convergence of all parameters was assessed, the posterior median value and posterior standard deviation for the expected number of BC cases in each age group were extracted.
results
In Spain, 100 704 BC deaths were observed during the period 1977-2001. Figure 1 shows the pattern of age-specific BC mortality rates by birth cohort and period of death. This graphic shows the decrease of BC mortality in the last two 5-year periods for all age groups. An increase in BC mortality rates in women older than 60 years was detected, whereas BC mortality decreased for women younger than 44 years. There is a significant increase in global BC mortality in all age groups until 1991 (EAPC 2.18%; 95% CI 1.99 to 2.39). The highest increase was observed among women older than 65 years (EAPC = 2.66%; 95% CI 2.26 to 3.09), whereas the lowest was detected in women younger than 44 years (EAPC = 1.38%; 95% CI 1.12 to 1.69). A significant decline in BC mortality rates was observed for all age groups after 1992 (EAPC = ÿ2.67%; 95% CI ÿ2.97 to ÿ2.31), being smaller among women older than 65 (EAPC = ÿ1.51; 95% CI ÿ1.71 to ÿ1.25). Table 2 shows the model selection procedure for the APC analysis. A significant increase in deviance (DDEV) was achieved for the models which depart from the full APC model, which had the lowest AIC value (AIC = 631). This was an indicator that cohort and period effects should be taken into account. The DDEV was higher for the AC model (DDEV = 379.9) than for the age-period model (DDEV = 311.4), and this indicates that the period effect was found to be more important than the cohort effect. An APC analysis with data from 1977 to 1991 (Table 3) , however, revealed that cohort effect was the most important factor to explain the variability of BC mortality rates during that period. In this last analysis, an AC model would be enough to explain variability of rates because a non-statistically significant DDEV between the APC (DEV = 13.9) and the AC (DEV = 16.1; P = 0.15) models was found. For that reason, the strength of the period effect during the study period 1977-2001 was due to the decrease in mortality trends from 1992 onwards. In women older than 50 years, however, BC projections showed an increase for each basis period (range from 10% to 40%), with a rise in the standard errors when calendar period increases. Figure 3 shows projections of the BC mortality rates in Spain for the period 2002-2016 by 5-year age groups and birth cohorts, on the basis of the four previous scenarios. The observed BC mortality is represented by solid lines, whereas the projected BC mortality is represented by dashed lines. On the This study has shown that women born before the 1950s were at higher risk of death by BC than women born after that decade (cohort effect). Similar cohort effects were reported in a recently published study conducted among new member states of the European Union [3] . In that study, a decline in BC mortality among young and middle-aged women attributed to stage distribution was detected, whereas in elderly women a continued rise of mortality was observed [3] . Another Spanish study carried out in Andalusia during the period 1975-1999 showed results in agreement with ours. This study reported lower BC risk of death in women born after the 1960s [10] .
The relevance of this cohort effect on BC mortality has been assessed during the period 1977-1991, before the implementation of BC-screening programmes in Spain. The role of the BC screening in BC mortality was evaluated during the period 1985-1997 in European countries such as England and Wales, Finland, Iceland, Netherlands, Scotland and Sweden [8] , all of them with national screening programmes. A statistically significant decline in BC mortality in all age groups was found in all these countries. In the same study, countries without national BC screening, such as Czech Republic, Denmark, Estonia, France, Italy, Norway, Slovakia, Slovenia, Switzerland and Spain, did not show a decrease in BC mortality in women older than 65 years [8] . Several BC-screening programs in different regions of Spain were started between 1990 and 1996, covering the whole female Spanish population aged 50-69 since the beginning of 2000 [34] . The decline in BC mortality among young women detected in our study could not be attributed to the BC population-screening programmes. However, opportunistic screening as well as a progressive awareness of the need for early detection, both among physicians and among women, led to a more favourable stage distribution related with early detection [35, 36] .
Some changes in lifestyles in the Spanish population could also explain the cohort effect observed in our study. Past consumption of meat and particularly beef meat seems to be associated with current BC mortality rates in Spain [37] . It has been also described that obesity increases the risk of BC in post-menopausal women [38] . A recent study estimated that original article
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approximately 80% of the Spanish population older than 60 years of age were overweight or obese [39] . In addition, the increase of BC mortality in older Spanish cohorts could be explained by other BC risk factors, such as alcohol consumption, oral contraceptives and hormonal replacement therapy [40] [41] [42] . On the contrary, the decline of some BC protector habits, such as breast-feeding, could explain the increase of BC incidence observed in women older than 40 in Catalonia during the period 1980-1999 [43] . The decline in BC mortality during the last two 5-year periods in all age groups detected in our study (period effect) suggests that early BC detection and the effect of various systemic adjuvant therapies have an effect on BC survival. A worldwide meta-analysis conducted among BC cases reported a 47% reduction of BC recurrences and 26% of BC mortality after tamoxifen implementation [44, 45] . Because tamoxifen was introduced in Spain in the early 1980s [46] , this treatment could partially explain the fall of BC mortality since the mid-1990s. The interpretation of these results should take into account several limitations. The first one is the Spanish population growth related to immigration. In Europe, between 1990 and 2004, the most significant growth in the percentage of immigrants was observed in Luxembourg and in Spain [47] . The annual increase of immigrants in Spain could affect the precision of future population-estimated figures. In order to cope with this limitation, we have compared these trends with different population distributions and all of them showed the same pattern that we have described with the data used in this analysis. Second, the predicted number of BC deaths could be overestimated if improvements in treatment take place. As an example, it has recently been reported that trastuzumab improves BC survival in women with HER2-positive metastatic BC [48] and in the adjuvant treatment [49] . Improvements in BC treatment may entail changes in the natural history of this cancer, and its mortality could be modified. To avoid this limitation, the further step in prediction analyses should be to develop simulation models that incorporate the natural history of BC [50, 51] . Outcomes from these simulation models could then be used for forecasting (rather than projection) purposes of BC mortality. Forecasts use additional information in conjunction with the APC model, whereas projections extrapolate a model into the future [22] . This last aspect was the aim of our analysis, for which we assumed the limitation that current and past trends continue without change. A third limitation of our study is the possibility of underestimation of Table 4 . Projection of the number of deaths by BC in Spain for the periods 2002-2006, 2007-2011, 2012-2016 1977-2001, 1982-2001, 1987-2001 and 1992-2001 BC mortality in the years to come. Our study predicts an increase in BC mortality in women older than 50 being mainly attributable to the ageing population which is sometimes neglected in interpreting predictions [52] , and an increase, in absolute numbers, due to immigration. In addition, a proportion of the BC diagnosed will remain non-cured among older people, despite the improvements in BC-relative survival observed in the last decade [53, 54] . A study carried out in Finland suggested that BC diagnosed among women younger than 50 remains a chronic disease which affects prognosis for decades [55, 56] . This issue could increase the expected BC mortality in patients older than 50, and it should be reflected with an underestimation in the future BC-deceased cases.
In Spain, studies of long-term BC survival should be carried out in order to assess BC curability. Outcomes of these studies would be also useful for future forecasting studies of BC mortality. In summary, the projections of BC mortality in Spain during 2002-2016 would suggest an increase in the number of BC cases among women aged 50 or older, specially among those older than 65. The fact that Spanish BC incidence is increasing in women older than 40 years [43] makes the projected BC mortality trends consistent with incidence data. This finding points out the need for further effort in BC prevention through screening is Spain, which has only been recently implemented in all territories and would have only a minor effect in the observed trends but a significant impact in the years to come. Changes in treatment could also have an impact in the projections of BC mortality in a positive direction. These projections could be useful in order to assess the consequences of cancer control policies in the most common form of cancer among women in both developing and developed countries [5] . Future forecasting studies should be carried out considering these new factors in the natural history of BC in Spain. appendix autoregressive APC model for projections of mortality rates and expected number of deceased cases
In order to smooth effects on each scale on time, Gaussian autoregressive prior models in the forward direction were proposed by Breslow and Clayton [57] and later by Berzuini and Clayton [58] and Bray [23] [24] [25] . In these models, it was assumed that second-order differences are independent normal covariates. Trends corresponding to age, period, and birth cohort were smoothed using second-degree autoregressive smoothing (non-parametric smoothing with autoregressive error component). For age, period, and cohort, these resulted in linear extrapolations.
Let a, b and c be the age, period, and cohort effects. In our final model, we have constrained the age effect, assuming that one second-order difference is estimated as the mean on the previous and subsequent second-order differences. So the age effect in this APC parameterisation is defined as a i ja j ; j 6 ¼ i Nðl ai ; s a Þ; original article Annals of Oncology
